Copyright
©The Author(s) 2020.
World J Gastroenterol. Aug 7, 2020; 26(29): 4327-4342
Published online Aug 7, 2020. doi: 10.3748/wjg.v26.i29.4327
Published online Aug 7, 2020. doi: 10.3748/wjg.v26.i29.4327
Figure 4 Kaplan-Meier curves of the estimated overall survival and recurrence-free survival of patients with sarcomatoid or high-grade hepatocellular carcinoma stratified by American Joint Committee on Cancer stage.
A: Sarcomatoid hepatocellular carcinoma (HCC) is associated with worse overall survival (OS) in patients with American Joint Committee on Cancer (AJCC) stage I-II disease (log-rank P < 0.0001); B: Sarcomatoid HCC is associated with worse recurrence-free survival (RFS) in patients with AJCC stage I-II disease (log-rank P = 0.0004); C: Sarcomatoid HCC is associated with worse OS in patients with AJCC stage III-IV disease (log-rank P = 0.0004); D: Sarcomatoid HCC is associated with worse RFS in patients with AJCC stage III-IV disease (log-rank P = 0.0004).
- Citation: Wang JP, Yao ZG, Sun YW, Liu XH, Sun FK, Lin CH, Ren FX, Lv BB, Zhang SJ, Wang Y, Meng FY, Zheng SZ, Gong W, Liu J. Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma. World J Gastroenterol 2020; 26(29): 4327-4342
- URL: https://www.wjgnet.com/1007-9327/full/v26/i29/4327.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i29.4327